The Cholecystitis Treatment Industry is poised for significant growth, driven by the increasing global prevalence of gallstones and the continuous advancement in minimally invasive surgical and pharmacological therapies. Cholecystitis, the inflammation of the gallbladder, primarily occurs due to gallstone obstruction, making the development of effective, low-morbidity treatments a key...